American Medical Association Published Language for New Codes for Psychedelic-Assisted Therapies
SAN JOSE, Calif., July 6, 2023 /PRNewswire/ -- MAPS Public Benefit Corporation ("MAPS PBC"), a clinical-stage company dedicated to changing the way mental health conditions are treated, announced that the American Medical Association ("AMA") has published language for the new current procedural terminology ("CPT") III codes for psychedelic-assisted therapies. The codes are expected to go into effect when they are published on January 1, 2024. Once effective, the CPT codes will provide physicians and other qualified healthcare professionals a means to seek coverage and reimbursement for delivering psychedelic-assisted therapy approved by the U.S. Food and Drug Administration ("FDA").
- The codes are expected to go into effect when they are published on January 1, 2024.
- Once effective, the CPT codes will provide physicians and other qualified healthcare professionals a means to seek coverage and reimbursement for delivering psychedelic-assisted therapy approved by the U.S. Food and Drug Administration ("FDA").
- On March 3, 2023 the AMA published the Summary of Panel Actions which included the acceptance of the new CPT III codes.
- The first code (0820T) is for a health care professional to be reimbursed for monitoring and intervention during a psychedelic-assisted therapy.